ELISA versus Nested PCR for Detection of Hepatitis B Co-infection in HIV-infected People in Bandung Indonesia


The number of Human Immunodeficiency Virus infected patients in Bandung is increasing. HIV patients are often suffering from Hepatitis B Virusco-infection. The co-infection status must be detected using the accurate method. This study aims to compare the accuracy of Enzyme-Linked Immunosorbent Assay and nested Polymerase Chain Reaction in detecting HIV-HBV co-infection in Bandung. The research method used is experimental. The sample used in this study was 50 people. All samples had met the inclusion criteria. The presence of hepatitis B surface antigen in the serum was detected using a qualitative ELISA Wantai kit, while sHBsAg gene in the whole blood was amplified using 2 pairs of the specific primary. The results obtained from both methods were analyzed to determine sensitivity, specificity, and accuracy values. The result of Hepatitis B detection using ELISA method showed that 15 samples (30%) were positive, 1 sample (2%) was a false positive, and 3 samples (6%) were the false negative. Moreover, the nested PCR method showed that 18 samples (36%) were positive without false positive or false negative result. These results showed that ELISA has a sensitivity value of 83.33%, specificity of 96.87%, and the accuracy of 92%, while Nested PCR has a value of 100% for all three parameters. Therefore, it can be concluded that the Nested PCR method was more accurate than ELISA to detect Hepatitis B co-infection in HIV patients in Bandung.The Nested PCR can be recommended for detecting the other co-infection cases.


Keywords: accuracy, HBsAg, co-infection, sensitivity, specificity

[1] Agyeman, A. A. and Ofori-Asenso, R. (2016). Prevalence of HIV and Hepatitis B Coinfection in Ghana: A Systematic Review and Meta-Analysis. AIDS Research and Therapy, vol. 13, issue 1. DOI: 10.1186/s12981- 016-0107-x

[2] Amin, M. (2019). A Comparative Study of Screening of Hepatitis B by Two Different Immunochromatographic Methods among Patients Attending a Tertiary Care Hospital. International Journal of Current Microbiology and Applied Sciences, vol. 8, issue 4, pp. 1506–1513.

[3] Amini, A., et al. (2017). Diagnostic Accuracy of Tests to Detect Hepatitis B Surface Antigen: A Systematic Review of the Literature and Meta-Analysis. BMC Infectious Diseases, vol. 17, issue S1, DOI: 10.1186/s12879-017-2772-3

[4] Asaduzzaman, M., et al. (2018). Comparison Between Rapid ICT And ELISA Tests For The Detection Of HBsAg; And Screening Of Hepatitis B Infection In Apparently Healthy Bangladeshi Outbound Staff. The International Journal of Engineering and Science, vol. 7, issue 9, pp. 34–39.

[5] Bolad, A., Hashim, M. and Lutfi, M. (2011). Reliability of Polymerase Chain Reaction (PCR) for Detection of Hepatitis B virus (HBV) in Healthy Blood Donors as Compared to That of Enzyme-Linked ImmunoSorbent Assay (ELISA). Alneelain Medical Journal.Vol. 1, issue 3, pp. 33–37.

[6] Bratanata, J., Gani, R. A. and Karjadi, T. H. (2015). Proporsi Infeksi Virus Hepatitis B Tersamar pada Pasien yang Terinfeksi Human Immunodeficiency Virus. Jurnal Penyakit Dalam Indonesia, vol. 2, issue 3, p. 126, https://doi.org/10.7454/jpdi.v2i3.77.

[7] Bratanata, J., Gani, R. A. and Karjadi, T. H. (2015). Proporsi Infeksi Virus Hepatitis B Tersamar pada Pasien yang Terinfeksi Human Immunodeficiency Virus. Jurnal Penyakit Dalam Indonesia, vol. 2, issue 3, p. 126, https://doi.org/10.7454/jpdi.v2i3.77.

[8] Chameera, E., et al. (2013). Diagnostic Efficacy of Rapid Assays used for the Detection of Hepatitis B Virus Surface Antigen. Sri Lankan Journal of Infectious Diseases, vol. 3, issue 2, p. 2, https://doi.org/ 10.4038/sljid.v3i2.5172.

[9] Dinas Kesehatan Provinsi Jawa Barat. (2016). Profil Kesehatan. Bandung: Dinas Kesehatan Provinsi Jawa Barat.

[10] Ew, M. M. R. and Prasetyo, A. A. (2015). Koinfeksi Virus Hepatitis B Terdeteksi pada Pasien HIV di Rumah Sakit Umum Dr. Moewardi di Surakarta. Bumi Lestari. Universitas Sebelas Maret

[11] Hayder, I., Ahmed, W. and Alam, S. E. (2012). Comparison of Different ICT Kits for HBsAg and Anti HCV using Gold Standard ELISA. Pakistan Journal of Medical Research, p. 5.

[12] Heathcote, E. J., et al. (2011). Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B. Gastroenterology, vol. 140, issue 1, pp. 132–143, https://doi.org/10.1053/j.gastro. 2010.10.011.

[13] Hønge, B. L., et al. (2014). Hepatitis B Virus Surface Antigen and Anti-Hepatitis C Virus Rapid tests Underestimate Hepatitis Prevalence among HIV-Infected Patients. HIV Medicine, vol. 15, issue 9, pp. 571–576, https://doi.org/10.1111/hiv.12158.

[14] Hudu, S. A., et al. (2016). Molecular and Serological Detection of Occult Hepatitis B Virus among Healthy Hepatitis B Surface Antigen-Negative Blood Donors in Malaysia. African Health Sciences, vol. 16, issue 3, pp. 677–683.

[15] Kementerian Kesehatan Republik Indonesia. (2018). Laporan Situasi Perkembangan HIV-AIDS & PIMS di Indonesia Januari - Desember 2017. Jakarta: Kementerian Kesehatan Republik Indonesia.

[16] Khan, J., et al. (2010). Evaluation of the Performance of Two Rapid Immunochromatographic Tests for Detection of Hepatitis B Surface Antigen and Anti HCV Antibodies Using Elisa Tested Samples. Special Edition Annals, vol. 16, issue 1, pp. 84–87.

[17] King, J. and Hagemeister, D. T. (2016). Hepatitis B Co-infection in HIV-Infected Patients Receiving Antiretroviral Therapy at the TC Newman Anti Retroviral Treatment Clinic in Paarl, Western Cape. Southern African Journal of HIV Medici.ne, vol. 17, issue 1, p. 3, https://doi.org/10.4102/sajhivmed.v17i1. 336

[18] Kourtis, A. P. and Jamieson, D. J. (2012). HIV–HBV Coinfection — A Global Challenge. The New England Journal of Medicine, p. 4.

[19] Kurdi, M., et al. (2014). Molecular Detection of Hepatitis B Virus (HBV) among Voluntary ELISA Positive Blood Donors in Almadinah Almunawwarah. Journal of Taibah University Medical Sciences, vol. 9, issue 2, pp. 166–170, https://doi.org/10.1016/j.jtumed.2014.01.002.

[20] Liu, Y., et al. (2010). Detection of Hepatitis B Virus DNA among accepted Blood Donors in Nanjing, China. Virology Journal, vol. 7, issue 1, p. 193, https://doi.org/10.1186/1743-422X-7-193.

[21] Madigan, M. T. (Ed.). (2012). Brock Biology of Microorganisms (13th ed.). San Francisco: Benjamin Cummings.

[22] Naully, P. G. and Romlah, S. (2018). Prevalensi HIV dan HBV pada Kalangan Remaja. Jurnal Kesehatan, vol. 9, issue 2, pp. 280–288, https://doi.org/10.26630/jk.v9i2.908.

[23] Nie, J.-J., et al. (2012). A Type-Specific Nested PCR Assay Established and Applied for Investigation of HBV Genotype and Subgenotype in Chinese Patients with Chronic HBV Infection. Virology Journal, vol. 9, issue 1, p. 121, https://doi.org/10.1186/1743-422X-9-121.

[24] Olotu, A. A., et al. (2016). Occult Hepatitis B Virus Infection in Previously Screened, Blood Donors in Ile-Ife, Nigeria: Implications for Blood Transfusion and Stem Cell Transplantation. Virology Journal, vol. 13, issue 1, https://doi.org/10.1186/s12985-016-0533-3.

[25] Owolabi, L. F. (2014). Prevalence and Burden of Human Immunodeficiency Virus and Hepatitis B Virus Co-infection in Nigeria: A Systematic Review and Meta-Analysis. Journal of AIDS & Clinical Research, vol. 5, issue 6, https://doi.org/10.4172/2155-6113.1000308.

[26] Ranjbar, R., et al. (2011). HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article. Iranian Red Crescent Medical Journal, vol. 13, issue 12, pp. 855–862.

[27] Sadeghi, A., et al. (2017). HBsAg Mutations related to Occult Hepatitis B Virus Infection in HIV-Positive Patients Result in a Reduced Secretion and Conformational Changes of HBsAg. Journal of Medical Virology, vol. 89, issue 2, pp. 246–256, https://doi.org/10.1002/jmv.24623.

[28] Saraswati, L. R., et al. (2015). HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India. BMC Public Health, vol. 15, issue 1, pp. 1–9, https://doi.org/10.1186/s12889-015-2003-z.

[29] Sepsatya, F. (2011). Spektrum klinis koinfeksi Human Immunodeficiency Virus (HIV) dengan Hepatitis B Virus (HBV) dan Hepatitis C Virus (HCV) di RSUP dr. Kariadi Semarang. (Skripsi, Universitas Diponegoro, Semarang, 2011).

[30] Taffon, S., et al. (2014). HBV Whole-Genome Mutation Profile in HIV-1/HBV Coinfected Patients in a Long-Term Follow-Up Study. Infection, vol. 42, issue 4, pp. 675–687, https://doi.org/10.1007/s15010- 014-0616-2.

[31] Wang, N., Zeng, N. N. and Zhu, W. (2010). Sensitivity, Specificity, Accuracy, Associated Confidence Interval and ROC Analysis eith Practical SAS Implementations, p. 9.

[32] Zhou, Y.-H., et al. (2012). High Prevalence of HIV, HCV, HBV and Co-Infection and Associated Risk Factors among Injecting Drug Users in Yunnan Province, China. PLoS ONE, vol. 7, issue 8, p. e42937, https://doi.org/10.1371/journal.pone.0042937.